Fred B Craves
CIK 1014095 · last filed 2025-03-14
Fred B Craves is a corporate insider who has filed 70 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for MDGL, was dated Aug 29, 2025. Across all open-market trades the lifetime net is −$217.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $162.9M across reported positions. 5 SEC filings were submitted jointly with MEDAREX INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MDGL price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
STE 600
SAN FRANCISCO, CA 94111
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MDGL | Director | 352,779 | $437.74 | $154.43M | -$220.59M | 26 | 2025-03-14 |
| TWST | Director | 58,168 | $145.25 | $8.45M | $0 | 2 | 2019-10-09 |
| DERM | Director | 9,000 | $4.97 | $44.7K | $1.80M | 8 | 2019-06-14 |
| PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Director | 635,739 | — | — | $1.00M | 21 | 2011-06-10 |
| VIA Pharmaceuticals, Inc. (VIAP) Delisted | Director | — | — | — | $0 | 1 | 2009-03-16 |
Recent Filings
70 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-08-29 | MDGL | Notice (144) | −2,900 | -$1.25M | EDGAR |
| 2025-08-20 | MDGL | Notice (144) | −1,000 | -$390.2K | EDGAR |
| 2025-08-18 | MDGL | Notice (144) | −2,000 | -$764.5K | EDGAR |
| 2025-08-15 | MDGL | Notice (144) | −4,100 | -$1.50M | EDGAR |
| 2025-03-14 | MDGL | Mixed | — | -$3.80M | EDGAR |
| 2025-03-13 | MDGL | Notice (144/A) | −7,728 | -$2.56M | EDGAR |
| 2025-03-13 | MDGL | Notice (144) | −7,742 | -$2.52M | EDGAR |
| 2025-03-12 | MDGL | Notice (144) | −7,428 | -$2.47M | EDGAR |
| 2024-12-05 | MDGL | Sell (S) | −3,600 | -$1.14M | EDGAR |
| 2024-11-27 | MDGL | Sell (S) | −3,400 | -$1.19M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.